372489005: Granisetron (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\5-HT3 receptor antagonist\Granisetron (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\5-HT3 receptor antagonist\Granisetron (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Granisetron (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Indazole (substance)\Granisetron (substance)
\Organic compound\Aza compound (substance)\Azabicyclo compound (substance)\Granisetron (substance)
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Granisetron (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Granisetron (substance)	Is a	5-HT3 receptor antagonist	true	Inferred relationship	Some
Granisetron (substance)	Is a	Azabicyclo compound (substance)	true	Inferred relationship	Some
Granisetron (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	5-HT3 receptor antagonist	true	Inferred relationship	Some
Granisetron (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Granisetron (substance)	Is a	Amide	true	Inferred relationship	Some
Granisetron (substance)	Is a	Indazole (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Granisetron hydrochloride (substance)	Is a	False	Granisetron (substance)	Inferred relationship	Some
Product containing granisetron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Granisetron (substance)	Inferred relationship	Some	1
granisétron 1 mg/mL, ampoule de 3 mL de concentré pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron (substance)	Inferred relationship	Some
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron (substance)	Inferred relationship	Some
granisétron 1 mg/1 mL, solution intraveineuse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron (substance)	Inferred relationship	Some
Granisetron 200micrograms/mL pediatric liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron (substance)	Inferred relationship	Some
Granisetron (as granisetron hydrochloride) 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron (substance)	Inferred relationship	Some
Granisetron hydrochloride 1mg/1mL injection solution 1mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron (substance)	Inferred relationship	Some
Granisetron hydrochloride 1mg/1mL injection solution 4mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron (substance)	Inferred relationship	Some
Granisetron 0.1mg/mL injection solution 1mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron (substance)	Inferred relationship	Some
Granisetron-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Granisetron (substance)	Inferred relationship	Some	1
Product containing granisetron in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Granisetron (substance)	Inferred relationship	Some	1
Granisetron 3.1mg/24hours transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron (substance)	Inferred relationship	Some
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Granisetron (substance)	Inferred relationship	Some	1
Granisetron (as granisetron hydrochloride) 2 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Granisetron (substance)	Inferred relationship	Some	1
Granisetron hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Granisetron (substance)	Inferred relationship	Some
Granisetron-containing product in transdermal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Granisetron (substance)	Inferred relationship	Some	1
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Granisetron (substance)	Inferred relationship	Some	1
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Granisetron (substance)	Inferred relationship	Some	1
Product containing precisely granisetron (as granisetron hydrochloride) 200 microgram/1 milliliter conventional release oral solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Granisetron (substance)	Inferred relationship	Some	1
Product containing precisely granisetron (as granisetron hydrochloride) 3 milligram/3 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Granisetron (substance)	Inferred relationship	Some	1
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Granisetron (substance)	Inferred relationship	Some	1
Granisetron only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Granisetron (substance)	Inferred relationship	Some	1
Product containing only granisetron in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Granisetron (substance)	Inferred relationship	Some	1
Granisetron only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Granisetron (substance)	Inferred relationship	Some	1
Granisetron only product in transdermal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Granisetron (substance)	Inferred relationship	Some	1
Granisetron (as granisetron hydrochloride) 1 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Granisetron (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1197782010	Granisetron (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211024016	Granisetron	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
49391000195110	granisetron	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
815241000172111	granisétron	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
63531000195110	Granisetron	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module